These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
738 related articles for article (PubMed ID: 17229689)
1. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. Zhu J; Huang X; Yang Y J Virol; 2007 Apr; 81(7):3170-80. PubMed ID: 17229689 [TBL] [Abstract][Full Text] [Related]
2. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Zhu J; Huang X; Yang Y Mol Ther; 2008 Jul; 16(7):1300-7. PubMed ID: 18443600 [TBL] [Abstract][Full Text] [Related]
3. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Yamaguchi T; Kawabata K; Koizumi N; Sakurai F; Nakashima K; Sakurai H; Sasaki T; Okada N; Yamanishi K; Mizuguchi H Hum Gene Ther; 2007 Aug; 18(8):753-62. PubMed ID: 17685831 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. Appledorn DM; Patial S; McBride A; Godbehere S; Van Rooijen N; Parameswaran N; Amalfitano A J Immunol; 2008 Aug; 181(3):2134-44. PubMed ID: 18641352 [TBL] [Abstract][Full Text] [Related]
5. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. Zhu J; Huang X; Yang Y J Clin Invest; 2009 Aug; 119(8):2388-98. PubMed ID: 19587448 [TBL] [Abstract][Full Text] [Related]
6. TANK-binding kinase 1-dependent or -independent signaling elicits the cell-type-specific innate immune responses induced by the adenovirus vector. Tsuzuki S; Tachibana M; Hemmi M; Yamaguchi T; Shoji M; Sakurai F; Kobiyama K; Kawabata K; Ishii KJ; Akira S; Mizuguchi H Int Immunol; 2016 Mar; 28(3):105-15. PubMed ID: 26489883 [TBL] [Abstract][Full Text] [Related]
7. Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectors. Rhee EG; Blattman JN; Kasturi SP; Kelley RP; Kaufman DR; Lynch DM; La Porte A; Simmons NL; Clark SL; Pulendran B; Greenberg PD; Barouch DH J Virol; 2011 Jan; 85(1):315-23. PubMed ID: 20962088 [TBL] [Abstract][Full Text] [Related]
8. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004 [TBL] [Abstract][Full Text] [Related]
9. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379 [TBL] [Abstract][Full Text] [Related]
10. NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo. Suzuki M; Cela R; Bertin TK; Sule G; Cerullo V; Rodgers JR; Lee B Hum Gene Ther; 2011 Sep; 22(9):1071-82. PubMed ID: 21561248 [TBL] [Abstract][Full Text] [Related]
11. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576 [TBL] [Abstract][Full Text] [Related]
13. NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. Zhu J; Huang X; Yang Y J Immunol; 2010 Dec; 185(12):7480-6. PubMed ID: 21076062 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Cerullo V; Seiler MP; Mane V; Brunetti-Pierri N; Clarke C; Bertin TK; Rodgers JR; Lee B Mol Ther; 2007 Feb; 15(2):378-85. PubMed ID: 17235317 [TBL] [Abstract][Full Text] [Related]
15. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Zhu J; Martinez J; Huang X; Yang Y Blood; 2007 Jan; 109(2):619-25. PubMed ID: 16973959 [TBL] [Abstract][Full Text] [Related]